EE Impact

Boehringer Ingelheim

Germany · Pharma & Healthcare

Also known as: Boehringer

LeaveRussia detail: Scaling Back

Scaling back

Boehringer Ingelheim is a German pharmaceutical company.

Status last verified 03/08/2026Source checked 29/03/2024Company website ↗LeaveRussia profile ↗

Decision trail

Reference ↗

Scale back to just supplying medicine. The media learned about the supply of veterinary drugs to Russia through “unofficial channels”.

Local stats (LeaveRussia)

Assets(RF), mln.USD
83
Capital(RF), mln.USD
26
Glob.Revenue, mln.USD
21778
Revenue(RF), mln.USD
284
Staff(RF), 2021
2546

Status history since 2022

  1. 03/08/2026 scaling back · Imported from KSE LeaveRussia

Exposure profile

Full exposure profile is a Professional feature

Energy, transport and commodity exposure, supplier/customer links in the region and sanctioned-party proximity.

Upgrade to Professional
Statuses, logos and narrative notes are compiled from public reporting and the KSE LeaveRussia project. Found an error? See our corrections policy.